For optimal preservation of the lyophilized LIPO-C powder, we recommend storing the vial in a refrigerator between 2C and 8C (36F and 46F)
Table 11: Results at Week 26 in a Trial Comparing TRESIBA to Insulin Glargine U-100 in Adult Patients with Type 2 Diabetes Mellitus on OAD(s)* Study G: TRESIBA Administered at the Same Time Each Day or Any Time Each Day as an Add-on to One and up to Three of the Following Oral Agents: Metformin, Sulfonylurea or Glinides or Pioglitazone in Adult Patients The efficacy of TRESIBA was evaluated in a 26-week randomized, open-label, multicenter trial in 687 patients with type 2 diabetes mellitus inadequately controlled on basal insulin alone, oral antidiabetic agents (OADs) alone or both basal insulin and OAD
These usually improve over time as your body adjusts to the medication
as such, the power of the statistical analyses may not have been robust and the generalizability of the results should be interpreted with caution
Molecular Basis for the Syndrome of 5-Reductase Type 2 Deficiency A reflection of defective or absence 5-reductase type 2 enzyme activity can be obtained in patients serum and urine samples by measuring testosterone levels (elevated), 5-dihydrotestosterone levels (decreased) and by measuring the ratio of testosterone/5-dihydrotestosterone (increased after hCG stimulation) (3)
